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Preoperative Extracorporeal Membrane Oxygenation
for Severe Ischemic Mitral Regurgitation
− 2 case reports −
Tae  Sik  Kim,  M.D.*,  Chan-Young  Na,  M.D.*,  Jong  Hyun  Baek,  M.D.*, 
Jae-Hyun  Kim,  M.D.*,  Sam-Sae  Oh,  M.D.*
Indication for extracorporeal membrane oxygenation (ECMO) has been extended as the experience of ECMO in 
various clinical settings accumulates and the outcome after ECMO installation improves. We report two cases of 
successful mitral valve surgery for severe ischemic mitral regurgitation in patients on ECMO support for cardiogenic 
shock which developed upon coronary angiography. 
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CASE REPORT
1) Case 1
A 65-year-old woman visited our emergency room with se-
vere  dyspnea.  Four  months  before,  the  patient  had  developed 
cardiogenic  shock  while  attempting  stent  insertion  (Endeavor 
3.0∼18
Ⓡ)  into  the  obstructed  left  main  coronary  artery 
(80%),  which  necessitated  urgent  institution  of  extracorporeal 
membrane  oxygenation  (ECMO)  and  intra-aortic  balloon 
pump.  After  coming  off  extracorporeal  life  support  systems, 
she  underwent  stenting  (Taxus  2.75∼38
Ⓡ)  of  the  obstructive 
left  anterior  descending  coronary  artery  (LAD),  which  re-
sulted in second attack of cardiogenic shock and ECMO sup-
port,  which  was  successfully  weaned  off.  She  had  been  dis-
charged  home  after  these  events,  and  had  been  followed  up 
in the outpatient department. On arrival at ER, her conscious-
ness  was  clear,  and  chest  x-ray  showed  pulmonary 
congestion.  Electrocardiogram  showed  acute  exacerbation  of 
chronic  myocardial  infarction.  On  echocardiography,  severe 
m i tr a l  r e g u r g i t a ti o n  d u e  t o  r e s t r i c t e d  v a lv e  m o ti o n  w a s  n o t e d ,  
and left ventricular ejection fraction was 28%. She developed 
the  third  attack  of  cardiogenic  shock  during  emergency  coro-
nary  angiogram,  and  was  put  on  ECMO  again  (Fig.  1). 
Coronary  angiogram  on  ECMO  support  showed  restenosis  of 
the  previous  LAD  stent  (80%)  and  complete  obstruction  of 
the  left  circumflex  and  right  coronary  arteries.  We  elected  to 
perform emergency coronary artery bypass grafting and mitral 
valve replacement. After ECMO circuit was converted to con-
ventional  cardiopulmonary  bypass  using  the  same  femoral  ar-
tery-vein  cannulae,  a  great  saphenous  vein  graft  was  anasto-
mosed  to  the  LAD  and  an  additional  saphenous  vein  graft 
was  placed  from  the  LAD  graft  to  the  posterior  descending ECMO for Severe Ischemic MR
− 237  −
Fig. 1. Preoperative chest X-ray (case 1) showing ECMO catheter 
and pulmonary venous congestion. ECMO=Extracorporeal mem-
brane oxygenation.
Fig. 2. Preoperative coronary angiogram under ECMO support in 
case 2 showing patent LAD stent which had been placed 4 mon-
ths before. ECMO=Extracorporeal membrane oxygenation; LAD=Left 
andterior descending coronary artery.
coronary  artery  in  an  inverted-Y  fashion.  Operative  findings 
of  the  mitral  valve  consisted  of  severe  fibrotic  change  of  the 
anterior  leaflet,  dilatation  of  the  mitral  valve  annulus,  and 
central  non-coaptation.  A  bioprosthetic  valve  was  placed 
while the native mitral valve leaflets were preserved. The pa-
tient  was  able  to  come  off  bypass  without  any  event. 
Cardiopulmonary  bypass  time  and  aortic  cross-clamping  time 
were  168  minutes  and  85  minutes,  respectively.  In  provision 
for the later postoperative use, we decided to leave the femo-
ral arterial  and  venous  cannulae  in  situ, which  were  removed 
on  postoperative  day  1.  She  was  extubated  on  postoperative 
day  4,  but  developed  superficial  wound  infection  with  de-
hiscence  which  was  repair  on  postoperative  day  36.  She  was 
finally discharged home on postoperative day 91. She was re-
admitted  in  2  months  after  discharge  due  to  general  weak-
ness,  fever,  and  septicemia.  Echocardiography  showed  7×3 
mm  sized  vegetation  at  the  prosthetic  mitral  valve,  and  bac-
teriologic examination identified methicillin-resistant Staphylo-
coccus  aureus  as  a  causative  microorganism.  Surgical  inter-
vention  was  recommended,  but  the  patient  refused  to  receive 
further  treatment  and  died  of  sepsis. 
2) Case 2
A  48-year-old  man  visited  our  emergency  room  with  se-
vere  dyspnea.  He  had  a  smoking  history  of  10  pack-years, 
and  had  been  followed  up  in  the  out-patient  clinic  for  sys-
temic hypertension, myocardial infarction and moderate mitral 
regurgitation. Four months before, he had undergone coronary 
artery  stenting  (Cypher  3.0∼33
Ⓡ)  to  relieve  complete  ob-
s t r u c t i o n  o f  L A D ,  w h i c h  r e s u l t e d  i n  t h e  d e t e r i o r a t i o n  o f  m i -
tral  regurgitation.  Surgical  treatment  for  the  mitral  valve  was 
suggested,  but  he  declined.  Echocardiography  at  this  admis-
sion  revealed  severe  mitral  regurgitation d u e  t o  r e s t r i c t e d  
valve  motion,  and  left  ventricular  ejection  fraction  was  30%. 
Upon  coronary  angiography,  he  developed  cardiogenic  shock, 
and  ECMO  was  installed.  Previous  LAD  stent  turned  out  to 
be patent on the coronary angiography (Fig. 2). Given severe 
pulmonary  edema  on  chest  X  ray  and  moderate  left  ven-
tricular  dysfunction,  we  elected  to  put  the  patient  on  ECMO 
temporarily  to  ameliorte  cardiopulmonary  function.  After  2 
days  of  ECMO  support,  the  pati e n t  w a s  b r o u g h t  t o  t h e  o p e r -
ating  room  and  cardiopulmonary  bypass  was  instituted  using 
the  same  femoral  arterial and  venous  cannulae.  An additional 
venous cannula was inserted into the superior caval vein after 
sternotomy  due  to  insufficient  venous  drainage  from  the  sin-
gle  femoral  venous  cannula.  Operative  findings  of  the  mitral 
valve  were  annular  dilatation  and  restrictive  motion  of  the Tae Sik Kim, et al
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posterior  leaflet.  Ring  annuloplasty  using  commercialized  mi-
tral  ring  (Carpentier-Edwards  Physio  ring  28  mm,  Edwards) 
was performed. The patient came off cardiopulmonary bypass 
without any event, and, differing from the 1st case, the femo-
ral arterial and venous cannulae were removed after the com-
pletion  of  the  procedures.  Intra-operative  trans-esophageal 
echocardiography  showed  mild  residual  mitral  regurgitation. 
Cardiopulmonary  bypass  time  and  aortic  cross-clamping  time 
were  103  minutes  and  53  minutes,  respectively.  The  patient 
was  extubated  on  postoperative  day  1,  and  echocardiography 
on  postoperative  day  19  showed  mild  to  moderate  residual 
mitral  regurgitation.  He  was  discharged  home  on  post-
operative day 29, and has been followed up for 14 months in 
a  good  clinical  condition. 
DISCUSSION
Coronary artery disease is frequently associated with mitral 
regurgitation. As benefits are substantiated by the meta-analy-
sis  of  the  reports  pertaining  to  the  outcome  of  surgical  inter-
vention  on  ischemic  mitral  regurgitation,  concomitant  mitral 
valve  surgery  upon  coronary  artery  bypass  grafting  is  recom-
mended  by  the  major  academic  bodies  in  north  America  (i.e. 
American  College  of  Cardiology,  American  Heart  Associa-
tion)  and  in  Europe  (i.e.  European  Society  of  Cardiology). 
Elimination of the left ventricular volume overloading by mi-
tral valve surgery is believed to be beneficial for the recovery 
of left ventricular function after coronary artery revasculariza-
tion  [1]. 
With  respect  to  the  types  of  mitral  valve  surgery,  either 
mitral valve replacement or mitral  annuloplasty could be per-
formed  according  to  the  disposition  of  valve  pathology  and 
patient  characteristics.  For  instance,  valve  replacement  is  rec-
ommended  in  case  of  papillary  muscle  rupture  or  leaflet  mo-
tion  restriction  caused  by  papillary  muscle  displacement  [2]. 
There are a number of reports asserting the superiority of the 
mitral  valve  repair  over  replacement  [3],  but  selection  from 
the  two  surgical  options  should  be  undertaken  based  on  the 
exact valve regurgitation mechanism of individual patients. In 
this  report,  the  first  patient  underwent  valve  replacement  due 
to the severe fibrotic change of the anterior leaflet, while ring 
annuloplasty alone was deemed appropriate to alleviate severe 
mitral  regurgitation  in  the  second  case. 
As  for  the  selection  of  the  life  support  system,  intra-aortic 
balloon  pump  (IABP)  has  been  widely  used  as  a  rescue 
measure for circulatory collapse. IABP is believed to improve 
left  ventricular  function  by  reducing  left  ventricular  afterload 
and  augmenting  coronary  perfusion  while  maintaining  pulsa-
tility  of  the  systemic  circulation.  However,  Barlett  et  al.  [4] 
claimed that ECMO is more beneficial for cardiogenic shock, 
given  that  patients  in  this  setting  may  need  both  circulatory 
and  pulmonary  support.  In  between  these  two  assertions, 
Wang  et  al.  [5]  proposed  that  IABP  is  indicated  for  patients 
with  coronary  artery  disease  while  ECMO  is  preferred  in  pa-
tients  with  valvular  heart  diseases.  In  our  first  case,  ECMO 
was  used  because  coronary  arteries  were  severely  obstructed 
and IABP alone might have not been effective. In the second 
case,  ECMO  was  indicated  to  alleviate  pulmonary  edema 
caused  by  severe  mitral  regurgitation.  Indications  for  ECMO 
or other percutaneous circulatory support systems are diverse, 
such  as  cardiac  arrest,  cardioge n i c  s h o c k ,  h i g h - r i s k  c a r -
diovascular  intervention,  bridge  to  emergency  cardiac  oper-
ation or cardiac transplantation, and pulmonary thromboembo-
lism  [6-10].  Nichol  et  al.  [11]  conducted  a  meta-analysis  of 
85  publications  between  1966  and  2005  regarding  percuta-
neous cardiopulmonary bypass, and concluded that this meas-
ure is mostly effective for rescuing critically ill patients, pro-
viding  the  median  survival  of  47%  in  1,495  patients  enrolled 
in  this  analysis.  In  the  literature,  however,  survival  rate  after 
instituting  mechanical  circulatory  support  widely  varies  be-
tween  15%  and  60%,  which  may  well  be  attributed  to  small 
number of patients in most of the reports, diversity of the un-
derlying diseases, and differences in experience and quality of 
care from one institution to another. It has been reported that 
selection  of  candidates,  timing  of  life  support  system  in-
stallation  and  technical  aspects  mainly  determine  the  survival 
[7,12]. 
Mechanical  circulatory  support  may  be  mandatory  upon 
coronary angiography or catheter intervention in  high-risk pa-
tients  with  cardiogenic  shock  or  uncontrolled  arrhythmia 
[13,14].  Shiraishi  et  al.  [15]  reported  that  mechanical  circu-
latory  support  was  necessary  in  275  (15.4%)  among  1,785 
patients  who  underwent  cardiovascular  intervention  for  acute 
myocardial  infarction.  With  respect  to  the  institution  of  life ECMO for Severe Ischemic MR
− 239  −
support  system  as  a  bridge  to  a  definitive  cardiac  operation, 
there  are  reports  of  successful  cardiac  operation  after  an  ur-
gent  installation  of  mechanical  circulatory  support  for  cardio-
genic  shock  which  developed  during  coronary  angiography. 
Grambow  et  al.  [16]  reported  20%  survival  in  patients  with 
circulator  assist  device  instituted  for  circulatory  collapse  in 
the  catheterization  laboratory.
For  the  percutaneous  circulatory  support,  we  are  using 
CAPIOX  emergency  bypass  system  (EBS;  Terumo  Inc, 
Tokyo, Japan), which consists of centrifugal pump, membrane 
oxygenator  (polypropylene  hollow  fiber)  and  heparin-coated 
circuit.  This  system  is  characterized  by  lower  heparin  admin-
istration,  longer  durability  of  the  oxygenator,  fast  and  easy 
auto-priming, and small-sized equipment with excellent adapt-
ability to a small space. It can also be easily manipulated by 
un-experienced  medical  personnel.  Thus,  we  have  an  institu-
tional strategy to institute EBS system as soon as possible in 
case  of  cardiogenic  shock  after  coronary  artery  angiography 
or  intervention,  and  this  might  have  lead  to  rescue  the  two 
patients  with  cardiogenic  shock  in  the  catheterization 
laboratory. 
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